Announcement

Collapse
No announcement yet.

J Intensive Med . Deep learning integration of chest computed tomography and plasma proteomics to identify novel aspects of severe COVID-19 pneumonia

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • J Intensive Med . Deep learning integration of chest computed tomography and plasma proteomics to identify novel aspects of severe COVID-19 pneumonia

    J Intensive Med


    . 2024 Dec 16;5(3):252-261.
    doi: 10.1016/j.jointm.2024.11.001. eCollection 2025 Jul. Deep learning integration of chest computed tomography and plasma proteomics to identify novel aspects of severe COVID-19 pneumonia

    Yucai Hong 1 , Lin Chen 2 3 , Yang Yu 2 , Ziyue Zhao 4 , Ronghua Wu 5 , Rui Gong 6 , Yandong Cheng 7 , Lingmin Yuan 7 , Shaojun Zheng 8 , Cheng Zheng 9 , Ronghai Lin 9 , Jianping Chen 10 , Kangwei Sun 10 , Ping Xu 11 , Li Ye 12 , Chaoting Han 11 , Xihao Zhou 13 , Yaqing Liu 14 , Jianhua Yu 14 , Yaqin Zheng 15 , Jie Yang 1 , Jiajie Huang 1 , Juan Chen 16 , Junjie Fang 16 , Chensong Chen 16 , Bo Fan 17 , Honglong Fang 18 , Baning Ye 19 , Xiyun Chen 20 , Xiaoli Qian 21 , Junxiang Chen 22 , Haitao Yu 23 , Jun Zhang 23 , Xi-Ming Pan 24 , Yi-Xing Zhan 24 , You-Hai Zheng 24 , Zhang-Hong Huang 25 , Chao Zhong 26 , Ning Liu 1 , Hongying Ni 27 , Gengsheng Zhang 28 , Zhongheng Zhang 1 29 30 ; Chinese Multi-omics Advances In Sepsis (CMAISE) Consortium



    AffiliationsAbstract

    Background: Heterogeneity is a critical characteristic of severe coronavirus disease 2019 (COVID-19) pneumonia. Integrating chest computed tomography (CT) imaging and plasma proteomics holds the potential to elucidate Image-Expression Axes (IEAs) that can effectively address this disease heterogeneity.
    Methods: A cohort of subjects diagnosed with severe COVID-19 pneumonia at 12 participating hospitals between December 2022 and March 2023 was prospectively screened for eligibility. Context-aware self-supervised representation learning (CSRL) was employed to extract intricate features from CT images. Quantification of plasma proteins was achieved using the Olink® inflammation panel. A deep learning model was meticulously trained, with CSRL features serving as input and the proteomic data as the target. This trained model facilitated the construction of IEAs, offering a representation of the underlying disease heterogeneity. The potential of these IEAs for prognostic and predictive enrichment was subsequently explored via conventional regression models.
    Results: The study cohort comprised 1979 eligible patients, who were stratified into a training set of 630 individuals and a testing set of 1349 individuals. Three distinct IEAs were identified: IEA1 was correlated with shock conditions, IEA2 was associated with the systemic inflammatory response syndrome (SIRS), and IEA3 was reflective of the coagulation profile. Notably, IEA1 (odds ratio [OR]= 0.52, 95 % confidence interval [CI]: 0.40 to 0.67, P < 0.001) and IEA2 (OR=0.74, 95 % CI: 0.62 to 0.90, P=0.002) exhibited significant associations with the risk of mortality. Intriguingly, patients characterized by lower IEA1 values (<-2, indicative of more severe shock) demonstrated a reduced mortality risk when administered with steroids. Conversely, patients with higher IEA2 values seemed to benefit from a judicious approach to fluid infusion.
    Conclusions: Our comprehensive approach, seamlessly integrating advanced deep learning techniques, proteomic profiling, and clinical data, has unraveled intricate interdependencies between IEAs, protein abundance patterns, therapeutic interventions, and ultimate patient outcomes in the context of severe COVID-19 pneumonia. These discoveries make a significant contribution to the rapidly advancing field of precision medicine, paving the way for tailored therapeutic strategies that can significantly impact patient care.

    Keywords: Covid-19; Heterogeneity; Self-supervised representation learning; Systemic inflammatory response syndrome.

Working...
X